Representing Shareholders, Employees, and Consumers for Over 30 Years
MiMedx_logo_CMYK.png

News

News & Investigations

News and Investigations

We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.

 

JELD-WEN Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty

5c5892a69b2cc.image.jpg

Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of JELD-WEN Holding, Inc. (NYSE: JELD) related to the company’s misrepresentations and omissions about its anticompetitive conduct violating federal antitrust and securities laws.

On February 15, 2018, a jury found JELD-WEN liable for violating federal antitrust laws. The presiding federal judge over the antitrust litigation issued detailed factual findings on October 5, 2018, exposing JELD-WEN’s anticompetitive behavior and ordered the company to divest a manufacturing facility. Then, on October 15, 2018, JELD-WEN disclosed that it was expected to incur $76.5 million in liability due to the antitrust verdict and revealed the sudden resignation of its Chief Financial Officer. The next day, JELD-WEN’s stock dropped by 19%.

This conduct has exposed the company to securities litigation in the U.S. District Court for the Eastern District of Virginia where it is alleged that defendants’ consistent misrepresentations and omissions intended to mislead the investing public by falsely attributing the source of the company’s financial success to legitimate and lawful pricing strategies. However, in reality, defendants were engaged in anticompetitive conduct in violation of federal antitrust laws which artificially inflated the company’s sales. On October 26, 2020, U.S. District Judge John A. Gibney, Jr. denied defendants’ motion to dismiss the case, finding that plaintiffs met the heightened pleading standards for alleged securities fraud, including alleging facts sufficient to create a “strong inference of scienter,” or intent to defraud investors.

If you currently own stock in JELD-WEN and wish to obtain additional information—or would like to participate in a potential shareholder derivative action—please complete the form below for a free legal consultation.